Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linhui Wang

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Cell Research|February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicingsShancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
European Urology|February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisFrancesco Greco, Riccardo Autorino, Koon H Rha, et al.
Cell Reports. Medicine|August 21, 2024
Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis predictionRui Sun, Jun A, Haolan Yu, et al.
BJU International|September 24, 2013
Analysis of oncological outcomes and renal function after laparoendoscopic single-site (LESS) partial nephrectomy: a multi-institutional outcome analysisChristopher Springer, Francesco Greco, Riccardo Autorino, et al.
Clinical Genitourinary Cancer|September 27, 2024
Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial CarcinomaJason Zappia, Courtney Yong, James Slaven, et al.
American Journal of Hematology|June 19, 2025
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical TrialYimei Feng, Linhui Wang, Mingqiang Ren, et al.
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
World Journal of Urology|October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology|June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Cell Research|February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicingsShancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
European Urology|February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisFrancesco Greco, Riccardo Autorino, Koon H Rha, et al.
Cell Reports. Medicine|August 21, 2024
Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis predictionRui Sun, Jun A, Haolan Yu, et al.
BJU International|September 24, 2013
Analysis of oncological outcomes and renal function after laparoendoscopic single-site (LESS) partial nephrectomy: a multi-institutional outcome analysisChristopher Springer, Francesco Greco, Riccardo Autorino, et al.
Clinical Genitourinary Cancer|September 27, 2024
Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial CarcinomaJason Zappia, Courtney Yong, James Slaven, et al.
American Journal of Hematology|June 19, 2025
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical TrialYimei Feng, Linhui Wang, Mingqiang Ren, et al.
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
World Journal of Urology|October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology|June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Pageof 23